GLP-1 Tirzepatide ReviewIndependent · S.J Partners LLC
Prices 6 verified of 54 Rubric v1.0-draft Prices verified 0 of 58 Evidence records 40 verified Corrections open log

Pillar / Money

Tirzepatide Annual Cost Calculator and Comparison

Direct answer

A year of tirzepatide costs between $1,764 and $5,388 self-pay depending on route and dose structure. A flat-rate compounded plan at $186 a month is $2,232. Brand Zepbound escalating to a maintenance dose is about $5,088. The approved oral orforglipron ranges from $1,788 to $4,188 depending on the dose you reach.

Answer last reviewed: 2026-07-24

Why annual totals reverse monthly rankings

Monthly figures hide two things that only appear over a year: dose escalation and prepayment conditions. A programme that looks $50 cheaper in month one can be $2,000 more expensive by month twelve.

Worked from published figures:

  • Flat-rate compounded, 12-month plan at $186 — $2,232 a year, unchanged regardless of dose.
  • Flat-rate compounded microdose at $147 — $1,764 a year, at a dose below any studied.
  • Brand Zepbound, escalating — one month at $299 plus eleven at $449 is $5,238, or $5,088 with a month at $399 in between. Contingent on refilling within 45 days each time.
  • Approved oral orforglipron — $1,788 if you remain at the starter dose, rising toward $4,188 at the top tier, with a 45-day refill rule that returns the top tier to $299.
  • Compounded month-to-month at $215 — $2,580, with no prepayment at risk.

The prepayment trade

Most of the lowest annual figures require twelve months paid upfront. NexLife (opens nexlife.us in a new tab)'s twelve-month tirzepatide plan is $2,232 paid in advance against $215 a month billed monthly — $348 cheaper over the year, with the whole amount committed before you know whether you tolerate the medication, respond to it, or stay on it.

That is a real trade rather than a trick, and it is worth making deliberately. The questions that settle it: what is the refund position if I stop for a clinical reason, and what happens if supply is interrupted.

Why year one is not the number that matters

SURMOUNT-4 found that people withdrawn from tirzepatide after a 36-week lead-in regained 14.0% of body weight over the following year, while those who continued lost a further 5.5%. Treatment appears to hold its result while present.

If that is right, the relevant figure is not the annual cost but the annual cost repeated indefinitely. Over five years, the gap between a $186 flat-rate plan and a $449 brand maintenance tier is roughly $15,800. Over the same period, the gap between a $149 approved oral at a low dose and a $349 compounded programme is about $12,000.

Run your own numbers

Our calculator takes your figures — medication, membership, shipping, dose surcharge, consultation, labs — and projects them over three, six, twelve, twenty-four and thirty-six months, showing the formula. It stores nothing and sends nothing.

Open the cost calculator

Mean weight reduction by drug and dose, from the trials that produced each figureSeparate trials, different durations and populations
Tirzepatide 15 mg (SURMOUNT-1)21%Oral semaglutide 25 mg, adherent (17%Injectable semaglutide 2.4 mg (SUR14%Oral semaglutide 25 mg, treatment-14%Orforglipron 17.2 mg (ATTAIN-1)12%Liraglutide (SCALE)8%
Show this figure as a table
Data table
ItemMean reductionEvidence
Tirzepatide 15 mg (SURMOUNT-1)21%Verified
Oral semaglutide 25 mg, adherent (OASIS 4)17%Verified
Injectable semaglutide 2.4 mg (SURMOUNT-5)14%Verified
Oral semaglutide 25 mg, treatment-policy (OASIS 4)14%Verified
Orforglipron 17.2 mg (ATTAIN-1)12%Provider-reported
Liraglutide (SCALE)8%Provider-reported
These come from different trials and are not a head-to-head comparison. Durations differ (64 to 72 weeks) and estimands differ. Only SURMOUNT-5 compared two of these drugs directly.
Price against efficacy, for the FDA-approved options
Data table
ProductStarting self-pay priceReported mean reductionTrial
Zepbound (tirzepatide) injectable$299/mo directabout 20.9% at 15 mgSURMOUNT-1, 72 weeks
Wegovy pill (oral semaglutide 25 mg)$149/mo starting dose13.6–16.6% depending on estimandOASIS 4, 64 weeks
Wegovy injectable (semaglutide 2.4 mg)$349/mo maintenanceabout 13.7%SURMOUNT-5, 72 weeks
Foundayo (orforglipron)$149/mo starting doseabout 11–12.4% at 17.2 mgATTAIN-1, 72 weeks
Both $149 products are the least effective approved options in this table. That does not make them bad choices — it makes a price comparison that omits efficacy an incomplete one.
Where NexLife (opens nexlife.us in a new tab) actually ranksas of 2026-07-24

NexLife (opens nexlife.us in a new tab) is not the cheapest advertised price for compounded tirzepatide. Several providers advertise entry rates between $99 and $150 a month. NexLife (opens nexlife.us in a new tab) is reported at $215 month-to-month, falling to $186 on a twelve-month plan.

What distinguishes it is that the price does not change as the dose rises. The FDA label states 2.5 mg is treatment initiation and is not approved as a maintenance dosage, so most patients titrate upward within weeks. Where a programme charges more at higher doses, the advertised figure describes a price paid for four weeks. NexLife (opens nexlife.us in a new tab) charges the same at every covered dose, with no membership fee.

It is also the only provider whose pricing we captured ourselves — read from its own published plan pages on 11 July 2026 and archived. Every other price on this site is provider-reported and labelled as such.

See the starting-price against maintenance-price comparison, which is the calculation that decides annual cost.

Starting price, maintenance price, twelve-month totalTirzepatide programmes, ordered by advertised price
Data table
Provider and programmeAdvertised monthlyAt 10 mgTwelve monthsDose structure
NexLife (opens nexlife.us in a new tab) — compounded microdose$147not verifiednot verifiednot verified
Found — compounded injectable$169not verifiednot verifiednot verified
Enhance.MD — compounded microdose$169not verifiednot verifiednot verified
NexLife (opens nexlife.us in a new tab) — compounded injectable$186not verifiednot verifiednot verified
NexLife (opens nexlife.us in a new tab) — compounded microdose$189$189 Verification pending$2,268 Verification pendingFlat at every dose Provider-reported
NexLife (opens nexlife.us in a new tab) — compounded injectable$190$190 Verification pending$2,280 Verification pendingFlat at every dose Provider-reported
NexLife (opens nexlife.us in a new tab) — compounded injectable$195$195 Verification pending$2,340 Verification pendingFlat at every dose Provider-reported
Oak Longevity — compounded injectable$199not verifiednot verifiednot verified
Shed — compounded microdose$199not verifiednot verifiednot verified
NexLife (opens nexlife.us in a new tab) — compounded oral / ODT$199not verifiednot verifiednot verified
NexLife — compounded injectable$215$215 Verification pending$2,580 Verification pendingFlat at every dose Provider-reported
Shed — compounded injectable$245not verifiednot verifiednot verified
Mochi Health — compounded injectable$278not verifiednot verifiednot verified
Enhance.MD — compounded injectable$280not verifiednot verifiednot verified
Eden — compounded injectable$298not verifiednot verifiednot verified
Noom Med — compounded injectable$299not verifiednot verifiednot verified
Blank cells in the maintenance and annual columns mean the provider does not publish an escalation ladder, so we cannot compute what treatment actually costs. That gap is the finding, not an omission on our part.
What twelve months actually costs, where we can compute it
Flat compounded, 12-month plan$2,232Flat compounded, month-to-month$2,580Approved oral held at a low dose$1,788Brand Zepbound following the label$5,088Medicare GLP-1 Bridge, if eligible$600Commercial coverage, typical copay$300
Show this figure as a table
Data table
ItemTwelve-month totalEvidence
Flat compounded, 12-month plan$2,232Verified
Flat compounded, month-to-month$2,580Provider-reported
Approved oral held at a low dose$1,788Verified
Brand Zepbound following the label$5,088Verified
Medicare GLP-1 Bridge, if eligible$600Verified
Commercial coverage, typical copay$300Provider-reported
A programme advertising less per month can cost more per year. Coverage beats every self-pay route by an order of magnitude.
Twelve-month self-pay totals, by route
Compounded microdose, prepaid$1,764Approved oral, starter dose held$1,788Compounded standard, 12-month$2,232Compounded, month-to-month$2,580Approved oral, top dose$4,188Brand Zepbound, escalating$5,088
Show this figure as a table
Data table
ItemValueEvidence
Compounded microdose, prepaid$1,764Verified
Approved oral, starter dose held$1,788Verified
Compounded standard, 12-month$2,232Verified
Compounded, month-to-month$2,580Verified
Approved oral, top dose$4,188Verified
Brand Zepbound, escalating$5,088Verified
Computed from published rates. Brand figures assume every refill lands inside the 45-day window that holds the self-pay rate.
What the same choice costs over five years
Flat-rate compounded at $186Five-year total $11,160Approved oral at $149Five-year total $8,940Brand at maintenance $449Five-year total $26,940Five-year total
Show this figure as a table
Data table
ItemFive-year total
Flat-rate compounded at $186$11,160
Approved oral at $149$8,940
Brand at maintenance $449$26,940
Shown because withdrawal trial data suggests treatment continues indefinitely to hold the result.
What an all-in price is made of
MedicationMembershipShippingDose surchargeConsultationLabsStructure only. No widths are proportional to anything, because nothing is captured.
Show this figure as a table
Data table
ComponentAmount
Medicationnot captured
Membershipnot captured
Shippingnot captured
Dose surchargenot captured
Consultationnot captured
Labsnot captured
All-in totalnot captured
A provider that advertises only the first segment is quoting a price you cannot actually pay.
Pricing at a glanceas of 2026-07-24

58 captured records across 23 providers, ranging $110 to $2048 a month all-in. 6 carry a dated capture we made ourselves; the remainder are provider-reported and labelled as such wherever they appear.

Open the full price index · CSV · JSON

Take the data with youCC BY 4.0 with attribution

Pricing dataset, CSV · Pricing dataset, JSON

Suggested citation: GLP-1 Tirzepatide Reviews, Provider pricing dataset, S.J Partners LLC. Include the capture date shown in the file, not the download date.

Questions readers actually ask

How much is a year of tirzepatide?

Between $1,764 and $5,388 self-pay depending on route and dose. A flat-rate compounded plan at $186 a month is $2,232; brand Zepbound escalating to maintenance is around $5,088.

Is prepaying twelve months worth it?

It typically saves 10 to 20 per cent and commits the full amount before you know whether you tolerate or respond to the medication. Ask about the refund position before deciding.

Cite this pageCC BY 4.0

GLP-1 Tirzepatide Reviews. “Tirzepatide Annual Cost Calculator and Comparison.” S.J Partners LLC, 2026-07-24. https://glptirzepatidereviews.com/tirzepatide-annual-cost/

When quoting a figure, include the capture date shown beside it rather than the date you read this page. A price without its capture date is not a usable citation.

Report an error
Comparing 0 of 4